Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2024 Aug 15;14(17):13049–13054. doi: 10.1021/acscatal.4c04568

Stereoselective Fe-Catalyzed Decoupled Cross-Couplings: Chiral Vinyl Oxazolidinones as Effective Radical Lynchpins for Diastereoselective C(sp2)–C(sp3) Bond Formation

Tapas Maity 1, Ángel Rentería-Gómez 1, Osvaldo Gutierrez 1,*
PMCID: PMC11385348  PMID: 39263540

Abstract

graphic file with name cs4c04568_0006.jpg

Modular, catalytic, and stereoselective methods for the dicarbofunctionalization of alkenes can streamline the synthesis of chiral active pharmaceutical ingredients (APIs) and agrochemicals. However, despite the inherent attractive properties of iron as catalysts for practical pharmaceutical synthesis (i.e., less expensive, more abundant, less toxic, and lower carbon footprint in comparison to other transition metals), iron-based catalytic methods that enable highly stereoselective dicarbofunctionalization of alkenes are lacking. Herein, we report the use of readily available chiral vinyl oxazolidinones as effective chiral radical lynchpins to enable practical and diastereoselective (up to 1:78 dr) Fe-catalyzed dicarbofunctionalization with fluoroalkyl halides and hetero(aryl) Grignard reagents. Experimental and computational mechanistic studies are carried out to elucidate the origin of stereoinduction and to build a stereochemical model for the rational reaction design.

Keywords: iron, cross-couplings, radicals, catalysis, diastereoselective, difunctionalization

Introduction

Alkenes are versatile building blocks in chemical synthesis.1 Driven by the pharmaceutical industry’s drive to “escape from flatland” by developing practical synthetic methods by increasing carbon bond saturation and/or installation of new chiral centers in drug candidates,2 transition metal-catalyzed three-component dicarbofunctionalization (DCF) of alkenes has emerged as an effective and highly versatile strategy.3 In pharmaceutical synthesis, methods for the selective installation of new C(sp3)–fluoroalkyl bonds are highly desirable due to the well-known ability of the difluoro methylene group (−CF2−)4 to improve lipophilicity, bioavailability, and metabolic stability of biologically active molecules. Notably, in some cases, molecules that bear C(sp3)–CF2R motifs have shown even more desirable properties than those with more traditional and “flat-like” C(sp2)–CF3 and C(sp2)–CF2H bonds.5

However, the use of sp3-hybridized coupling partners, especially sp3-fluoroalkyls, in transition metal-catalyzed three-component DCF of alkenes still faces significant hurdles for practical applications. For example, palladium catalysts have been extensively used in this context.3,6 However, the high cost, increased carbon footprint, and localized global mining access of palladium coupled with slow rates for oxidative addition to sp3-hybridized electrophiles and facile β-H elimination can limit their broad applicability especially in large-scale pharmaceutical synthesis.6b Recently, nickel- and copper-based catalytic systems have emerged as potentially more sustainable alternative and complementary strategies to enable selective DCF of alkenes using sp3-hybridized electrophiles or nucleophiles.7,8 Nonetheless, in contrast to other transition metals, iron is less expensive, more abundant, and less toxic and produces significantly less carbon footprint. These attractive properties make iron a highly desirable catalyst for practical pharmaceutical synthesis.9,10 In this vein, our group has pioneered the use of inexpensive iron salts in combination with commercially available ligands to enable selective three-component DCF of alkenes using alkyl halides and sp2-hybridized Grignard reagents as coupling partners.11,12

In contrast to their two-component variants, methods for stereoselective transition metal-catalyzed three-component cross-couplings with alkenes are severely limited.7c In this context, although the use of Evan’s chiral oxazolidinones in practical asymmetric C–C bond formations in both academic and industrial settings is well-established,13 the complementary strategy that uses chiral (enantiopure) coupling partners to control the diastereoselectivity in transition-metal catalyzed DCF of alkenes is underdeveloped. Notably, there are sporadic methods that use enantiopure chiral coupling partners to control the diastereoselectivity in transition metal-catalyzed “two-component” cross-coupling reactions (Scheme 1A).14 Specifically, Knochel and co-workers reported the diastereoselective Pd-catalyzed cross-coupling of cyclic and open chain chiral zinc reagents with alkenyl iodides and alkyl chlorides albeit low yields.14a Oshima reported a cobalt-catalyzed diastereoselective cross-coupling between aryl Grignard reagents and optically pure bromo acetals.14b Under nickel catalysis, the Li group disclosed a cross-electrophile diastereoselective coupling to form a series of aryl-nucleosides.14c Finally, under chromium catalysis, the Knochel group reported a method for highly chemo- and diastereoselective Csp2–Csp3 cross-couplings.14d Herein, we report the development of the first highly diastereoselective and broadly applicable three-component DCF of alkenes using a bisphosphine-iron-catalyzed decoupled radical cross-coupling strategy using readily available chiral oxazolidinones with alkyl halides and (hetero)aryl Grignard reagents (Scheme 1B).

Scheme 1. Diastereoselective Cross-Coupling Reactions Using a Chiral Substrate.

Scheme 1

Results and Discussion

To initiate our studies, we selected chiral vinyl oxazolidinones as commercially available and modular α-amide radical precursors for Fe-catalyzed decoupled cross-coupling reactions. The basis for the choice of chiral alkene originates from (1) our recent report on DCF of enamides,15 (2) the wide use of Evans’ chiral auxiliaries in organic chemistry for practical and stereoselective construction of enantioenriched compounds,16 and (3) potential application in medicinal chemistry as oxazolidinones represent an important class of heterocyclic motifs found in many natural products, pharmaceuticals, and biologically active molecules.17 Moreover, the use of enantioenriched alkenes, including vinyl oxazolidinones, in three-component transition-metal catalyzed DCF of alkenes remains virtually unexplored.18 In this vein, we hypothesized that incorporating this chiral functionality into an alkene could be an alternative and practical strategy to achieve high stereocontrol of the C(sp3)–C(sp2) bond formation between iron-aryl species and alkyl radical, which remains a grand challenge in Fe-catalyzed radical cross-couplings.12a

Gratifyingly, after extensive screening (Supporting Information), we identified 4-benzyl-3-vinyloxazolidin-2-one (R)-4d bearing a benzyl substituent to give the highest diastereomeric ratio (dr 1:19) and good isolated yield of the desired product 4d (Scheme 2A). Notably, vinyloxazolidinone (4b) also gave good yields and high levels of diastereoselectivity. Other systems such as phenyl- and tBu-substituted oxazolidinone (4a and 4c) gave inferior results in terms of yield and/or selectivity. With the best chiral substrate in hand, we next examined the impact of the ligand on this diastereoselective decoupled cross-coupling (Scheme 2B). As in the past, the combination of iron(III) chloride with privileged 1,2-bis(dicyclohexylphosphino) ethane (dcpe) ligand gave the best NMR yield (91%).15 Notably, the use of 1,2-bis(diisopropylphosphino)ethane (dippe) provided the desired product but in lower yields (69%). Interestingly, bidentate nitrogen-containing ligands also worked in our system (25–39%). Additional control experiments (entries 3–4) confirmed that both iron precatalyst and ligand are essential to promote this transformation (entries 3–5).11b Lowering the catalyst and ligand loadings (from 10/20 to 5/10 mol %, entry 6) or modifying the aryl Grignard reagent (entry 2) resulted in lower yields. We note that the reaction proceeded smoothly at a larger scale (2.0 mmol), forming the desired product (R)-4d in 64% isolated yield.

Scheme 2. (A) Screening of the Chiral Substrate; (B) Deviations in the Optimized Reaction Conditions,,,,,

Scheme 2

Reaction conditions: 1 (0.2 mmol, 1.0 equiv), 2a (0.4 mmol, 2.0 equiv), FeCl3 (10 mol %), dcpe (20 mol %), THF (c 1.0 M), 0 °C, slow addition of 3a (0.8 mmol, 4.0 equiv) in 1 h, and nitrogen atmosphere; d.r. was determined by crude 1H NMR.

Determined by 1H NMR using 1,2-dibromomethane as an internal standard.

0.4 mmol 3a was used.

FeCl3 (5 mol %), dcpe (10 mol %).

yield (%) of isolated product of 2 mmol scale reaction.

Isolated yield (%).

With optimized conditions in hand, we next examined the generality of this diastereoselective radical cross-coupling reaction in terms of the nucleophile scope (Scheme 3). Notably, a wide range of aryl Grignard reagents were able to deliver the intended cross-coupling product with fluoroalkyl bromide 2a and (R)-4-benzyl-3-vinyloxazolidin-2-one 1a. For example, electron-poor and -rich substituents were also well tolerated in different positions with varying yields. Electron-donating groups, including -OMe (5b and 5o), –OCF3 (5j), and –F (5e) at the meta position were better suited for our conditions than at the para position. Furthermore, π-extended systems were also engaged with good efficiency with a high to moderate yield (85%, 5f, and 44%, 5m). N-/O- heterocycles, including carbazole (5r), indazole (5s), pyridine(5t), and benzofuran (5q), were also effective in conjunction with “turbo Grignard”, leading to bis-heterocycles in good yields (48–73%).19

Scheme 3. Scope of the Aryl Grignard Reagents for DS-CCR.

Scheme 3

Conditions: 1a (0.2 mmol), 2a (0.4 mmol), 3 (0.8 mmol), FeCl3(10 mol %), dcpe (20 mol %), THF (c 1.0 M), 0 °C, slow addition of 3 in 1 h, argon atmosphere, and d.r. was determined by crude 1H NMR.

We next proceeded to assess the substrate scope in terms of fluoroalkyl halides as radical precursors (Scheme 4). Overall, a broad spectrum of di-, tetra-, and perfluoro alkyl bromides as radical precursors carrying varied functionalities such as fluoroalkyl-rich (6a) chains, extended alkyls (6c), aryl (6j), aryl ethers with relevant functionalities (6eh), heteroaryl (6i), and diethoxyalkyl as protected aldehydes (6d) were compatible in this transformation. Notably, an α,α-difluoro ester bromide interacts in the reaction to obtain 6b in reasonable yield (59%). Not surprisingly, nucleophilic alkyl radicals did not participate in this iron-catalyzed three-component cross-coupling reaction (6k), consistent with the high energy barrier associated for polarity mismatched20 radical addition to electron-rich alkene.

Scheme 4. Scope of Fluoroalkyl Halides for DS-CCR,

Scheme 4

Conditions: 1a (0.2 mmol), 2 (0.4 mmol), 3a (0.8 mmol), FeCl3(10 mol %), dcpe (20 mol %), THF (c 1.0 M), 0 °C, slow addition of 3a in 1 h, and argon atmosphere.

tert-butyl iodide was used, and d.r. was determined by crude 1H NMR.

Finally, to confirm the formation of the Int-1 radical, we used tetrafluoroalkyl halide 2b with a pendent alkene as a “radical trap” (Scheme 5A). Under our optimized reaction conditions, this reagent led to the formation of cyclic compound 7 in 55% yield. Based on these results and previous reports,10b,11b,12,15 a plausible mechanism is shown in Scheme 5B. Fe(I) A can undergo halogen-atom abstraction to form the radical MeCF2CF2 and Fe (II) B species (energetically feasible by −17.3 kcal/mol).11b,12c Then, MeCF2CF2 can escape the solvent cage to undergo radical addition to N-vinyl compound (R)-1 to form Int (downhill in 20.3 kcal/mol via a low energy barrier of 8.4 kcal/mol) with the concomitant formation of Fe(II) B. Simultaneously, the gradual addition of Grignard reagent can facilitate selective monotransmetalation of B into C.11b Finally, Int will selectively and reversibly engage in radical addition to monoaryl Fe(II) C to form Fe(III) D that can then undergo reductive elimination to form the desired product. Consistent with the experiment, the energy difference between the two lowest energy diastereomeric transition states for the reductive elimination step is ∼2.2 kcal/mol (Scheme 5C) in favor of the (R,S) diastereomer.18 Closer inspection of the lowest energy diastereomeric transition states revealed an attractive C–H···O12a interaction in 4TS3-(R,S), which is absent in the competing transition state, as evident from the NCI (noncovalent interaction) plots. In addition, upon interaction with the cyclohexyl group, both transition states exhibit a considerable difference in CH–Fe distance (2.83 Å vs 2.42 Å). This could promote 4TS3-(R,S) to undergo C–C bond formation faster over 4TS3-(R,R).

Scheme 5. Mechanistic Studies.

Scheme 5

Conclusions

In conclusion, we have developed the first highly diastereoselective bisphosphine-iron-catalyzed radical cross-coupling reaction to enable 1,2-dicarbofunctionalization of chiral vinyl oxazolidinones with diverse (fluoro)alkyl halides and aryl Grignard reagents. Mechanistic probes are consistent with radical translocation to form an α-amide radical that is rapidly intercepted by a monoaryl bisphosphine-iron leading to diastereoselective carbon–carbon bond formation. Further studies to develop catalytic asymmetric synthesis using this strategy are in progress in our laboratory and will be reported in due course.

Acknowledgments

The authors acknowledge the NMR and Mass Spectrometry facilities in the Department of Chemistry at Texas A&M University and Texas A&M University HPRC resources for providing computational resources (https://hprc.tamu.edu).

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acscatal.4c04568.

  • Experimental procedures, product characterizations, DFT calculation data, and copies of the 1H and 13C NMR spectra (PDF)

Author Contributions

T.M. and A.R.G. contributed equally. The manuscript was written through the contributions of all authors. All authors have given approval to the final version of the manuscript.

We acknowledge the NIGMS NIH (R35GM137797) for funding.

The authors declare no competing financial interest.

Supplementary Material

cs4c04568_si_001.pdf (11.9MB, pdf)

References

  1. a Biju A. T.; Kuhl N.; Glorius F. Extending NHC-catalysis: Coupling Aldehydes with Unconventional Reaction Partners. Acc. Chem. Res. 2011, 44, 1182–1195. 10.1021/ar2000716. [DOI] [PubMed] [Google Scholar]; b Fustero S.; Simon-Fuentes A.; Barrio P.; Haufe G. Olefin Metathesis Reactions with Fluorinated Substrates, Catalysts, and Solvents. Chem. Rev. 2015, 115, 871–930. 10.1021/cr500182a. [DOI] [PubMed] [Google Scholar]
  2. Lovering F.; Bikker J.; Humblet C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J. Med. Chem. 2009, 52, 6752–6756. 10.1021/jm901241e. [DOI] [PubMed] [Google Scholar]
  3. a Derosa J.; Tran V. T.; van der Puyl V. A.; Engle K. M. Carbon–Carbon π Bonds as Conjunctive Reagents in Cross-Coupling. Aldrichimica Acta 2018, 51, 21–32. [Google Scholar]; b Giri R.; Shekar K. C. Strategies toward Dicarbo-functionalization of Unactivated Olefins by Combined Heck Carbometalation and Cross-Coupling. J. Org. Chem. 2018, 83, 3013–3022. 10.1021/acs.joc.7b03128. [DOI] [PubMed] [Google Scholar]; c Zhang J.-S.; Liu L.; Chen T.; Han L.-B. Transition-Metal-Catalyzed Three-Component Difunctionalizations of Alkenes. Chem.-Asian J. 2018, 13, 2277–2291. 10.1002/asia.201800647. [DOI] [PubMed] [Google Scholar]; d Wickham L. M.; Giri R. Transition Metal (Ni, Cu, Pd)-Catalyzed Alkene Dicarbofunctionalization Reactions. Acc. Chem. Res. 2021, 54, 3415–3437. 10.1021/acs.accounts.1c00329. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Gao P.; Niu Y.-J.; Yang F.; Guo L.-N.; Duan X.-H. Three-component 1,2-dicarbofunctionalization of alkenes involving alkyl radicals. Chem. Commun. 2022, 58, 730–746. 10.1039/D1CC05730H. [DOI] [PubMed] [Google Scholar]
  4. a O’Hagan D. Understanding Organofluorine Chemistry. An introduction to the C-F bond. Chem. Soc. Rev. 2008, 37, 308–319. 10.1039/B711844A. [DOI] [PubMed] [Google Scholar]; b Holovach S.; Melnykov K. P.; Skreminskiy A.; Herasymchuk M.; Tavlui O.; Aloshyn D.; Borysko P.; Rozhenko A. B. S.; Ryabukhin V.; Volochnyuk D. M.; Grygorenko O. O. Effect of gem-Difluorination on the Key Physicochemical Properties Relevant to Medicinal Chemistry: The Case of Functionalized Cycloalkanes. Chem.—Eur. J. 2022, 28, e202200331 10.1002/chem.202200331. [DOI] [PubMed] [Google Scholar]
  5. a Sorrentino J. P.; Altman R. A. Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability. ACS Med. Chem. Lett. 2022, 13, 707–713. 10.1021/acsmedchemlett.2c00055. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Inoue M.; Sumii Y.; Shibata N. Contribution of Organofluorine Compounds to Pharmaceuticals. ACS Omega 2020, 5, 10633–10640. 10.1021/acsomega.0c00830. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Ogawa Y.; Tokunaga E.; Kobayashi O.; Hirai K.; Shibata N. Current Contributions of Organofluorine Compounds to the Agrochemical Industry. iScience 2020, 23, 101467. 10.1016/j.isci.2020.101467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. a Dhungana R. K.; Shekar K. C.; Basnet P.; Giri R. Transition Metal-Catalyzed Dicarbofunctionalization of Unactivated Olefins. Chem. Rec. 2018, 18, 1314–1340. 10.1002/tcr.201700098. [DOI] [PubMed] [Google Scholar]; b Urkalan K. B.; Sigman M. S. Palladium-Catalyzed Oxidative Intermolecular Difunctionalization of Terminal Alkenes with Organostannanes and Molecular Oxygen. Angew. Chem., Int. Ed. 2009, 48, 3146–3149. 10.1002/anie.200900218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. a Derosa J.; Apolinar O.; Kang T.; Tran V. T.; Engle K. M. Recent Developments in Nickel-catalyzed Intermolecular Dicarbofunctionalization of Alkenes. Chem. Sci. 2020, 11, 4287–4296. 10.1039/C9SC06006E. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Luo Y.-C.; Xu C.; Zhang X. Nickel-Catalyzed Dicarbofunctionalization of Alkenes. Chin. J. Chem. 2020, 38, 1371–1394. 10.1002/cjoc.202000224. [DOI] [Google Scholar]; c Qi X.; Diao T. Nickel-Catalyzed Dicarbofunctionalization of Alkenes. ACS Catal. 2020, 10, 8542–8556. 10.1021/acscatal.0c02115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. a Zhu R.; Buchwald S. L. Copper-Catalyzed Oxytrifluoromethylation of Unactivated Alkenes. J. Am. Chem. Soc. 2012, 134, 12462–12465. 10.1021/ja305840g. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Zhu R.; Buchwald S. L. Versatile Enantioselective Synthesis of Functionalized Lactones via Copper-Catalyzed Radical Oxyfunctionalization of Alkenes. J. Am. Chem. Soc. 2015, 137, 8069–8077. 10.1021/jacs.5b04821. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Wang F.; Chen P.; Liu G. Copper-Catalyzed Radical Relay for Asymmetric Radical Transformations. Acc. Chem. Res. 2018, 51, 2036–2046. 10.1021/acs.accounts.8b00265. [DOI] [PubMed] [Google Scholar]; d Gu Q.-S.; Li Z.-L.; Liu X.-Y. Copper(I)-Catalyzed Asymmetric Reactions Involving Radicals. Acc. Chem. Res. 2020, 53, 170–181. 10.1021/acs.accounts.9b00381. [DOI] [PubMed] [Google Scholar]; e Li Z.-L.; Fang G.-C.; Gu Q.-S.; Liu X.-Y. Recent Advances in Copper-Catalysed Radical-Involved Asymmetric 1,2-Difunctionalization of Alkenes. Chem. Soc. Rev. 2020, 49, 32–48. 10.1039/C9CS00681H. [DOI] [PubMed] [Google Scholar]
  9. Mako T. L.; Byers J. A. Recent Advances in Iron-catalysed Cross Coupling Reactions and Their Mechanistic Underpinning. Inorg. Chem. Front. 2016, 3, 766–790. 10.1039/C5QI00295H. [DOI] [Google Scholar]
  10. a Neidig M. L.; Carpenter S. H.; Curran D. J.; DeMuth J. C.; Fleischauer V. E.; Iannuzzi T. E.; Neate P. G. N.; Sears J. D.; Wolford N. J. Development and Evolution of Mechanistic Understanding in Iron-Catalyzed Cross-Coupling. Acc. Chem. Res. 2019, 52, 140–150. 10.1021/acs.accounts.8b00519. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Sears J. D.; Neate P. G. N.; Neidig M. L. Intermediates and Mechanism in Iron-Catalyzed Cross-Coupling. J. Am. Chem. Soc. 2018, 140, 11872–11883. 10.1021/jacs.8b06893. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Fürstner A.; Leitner A.; Méndez M.; Krause H. Iron-Catalyzed Cross-Coupling Reactions. J. Am. Chem. Soc. 2002, 124, 13856–13863. 10.1021/ja027190t. [DOI] [PubMed] [Google Scholar]
  11. a Rotella M. E.; Sar D.; Liu L.; Gutierrez O. Fe-Catalyzed Dicarbofunctionalization of Electron-rich Alkenes with Grignard Reagents and (Fluoro)alkyl halides. Chem. Commun. 2021, 57, 12508–12511. 10.1039/D1CC04619E. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Liu L.; Aguilera M. C.; Lee W.; Youshaw C. R.; Neidig M. L.; Gutierrez O. General Method for Iron-catalyzed Multicomponent Radical Cascades Cross-couplings. Science 2021, 374, 432–439. 10.1126/science.abj6005. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Sar D.; Yin S.; Grygus J.; Rentería-Gómez Á.; Garcia M.; Gutierrez O. Expanding the Chemical Space of Enol silyl ethers: Catalytic Dicarbofunctionalization Enabled by Iron Catalysis. Chem. Sci. 2023, 14, 13007–13013. 10.1039/D3SC04549H. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Tan T.-D.; Serviano J. M. I.; Luo X.; Qian P.-C.; Holland P. L.; Zhang X.; Koh M. J. Congested C(sp3)-rich Architectures Enabled by Iron-catalysed Conjunctive Alkylation. Nat. Catal. 2024, 7, 321–329. 10.1038/s41929-024-01113-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. a Youshaw C. R.; Yang M. H.; Gogoi A. R.; Rentería-Gómez A.; Liu L.; Morehead L. M.; Gutierrez O. Iron-Catalyzed Enantioselective Multicomponent Cross-Couplings of α-Boryl Radicals. Org. Lett. 2023, 25, 8320–8325. 10.1021/acs.orglett.3c03387. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Lee W.; Zhou J.; Gutierrez O. Mechanism of Nakamura’s Bisphosphine-Iron-Catalyzed Asymmetric C(sp2)–C(sp3) Cross-Coupling Reaction: The Role of Spin in Controlling Arylation Pathways. J. Am. Chem. Soc. 2017, 139, 16126–16133. 10.1021/jacs.7b06377. [DOI] [PubMed] [Google Scholar]; c Aguilera M. C.; Gogoi A. R.; Lee W.; Liu L.; Brennessel W.; Gutierrez O.; Neidig M. L. Insight into Radical Initiation, Solvent Effects and Biphenyl Production in Iron-Bisphosphine Cross-Couplings. ACS Catal. 2023, 13, 8987–8996. 10.1021/acscatal.3c02008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Beutner G. L.; Cohen B. M.; DelMonte A. J.; Dixon D. D.; Fraunhoffer K. J.; Glace A. W.; Lo E.; Stevens J. M.; Vanyo D.; Wilbert C. Revisiting the Cleavage of Evans Oxazolidinones with LiOH/H2O2. Org. Process Res. Dev. 2019, 23, 1378–1385. 10.1021/acs.oprd.9b00124. [DOI] [Google Scholar]
  14. a Boudier A.; Knochel P. Palladium Catalyzed Stereoselective Cross-couplings and Acylations of Chiral Secondary Diorganozincs. Tetrahedron Lett. 1999, 40, 687–690. 10.1016/S0040-4039(98)02581-7. [DOI] [Google Scholar]; b Ohmiya H.; Yorimitsu H.; Oshima K. Cobalt(diamine)-catalyzed Cross-coupling Reaction of Alkyl halides with Arylmagnesium Reagents: Stereoselective Constructions of Arylated Asymmetric Carbons and Application to Total Synthesis of AH13205. J. Am. Chem. Soc. 2006, 128, 1886–1889. 10.1021/ja057560o. [DOI] [PubMed] [Google Scholar]; c Li Y.; Wang Z.; Li L.; Tian X.; Shao F.; Li C. Chemoselective and Diastereoselective Synthesis of C-aryl Nucleoside Analogues by Nickel-catalyzed Cross-coupling of Furanosyl acetates with Aryl iodides. Angew. Chem., Int. Ed. 2022, 134, e202110391 10.1002/anie.202110391. [DOI] [PubMed] [Google Scholar]; d Li J.; Ren Q.; Cheng X.; Karaghiosoff K.; Knochel P. Chromium(II)-catalyzed Diastereoselective and Chemoselective Csp2–Csp3 Cross-couplings using Organomagnesium Reagents. J. Am. Chem. Soc. 2019, 141, 18127–18135. 10.1021/jacs.9b08586. [DOI] [PubMed] [Google Scholar]
  15. Rentería-Gómez Á.; Guerrero M.; Ramirez-Lopez M.; Gutierrez O. Regioselective Fluoroalkylarylation of Enamides Enabled by an Iron-Catalyzed Multicomponent Radical Cross-Coupling Strategy. Org. Lett. 2023, 25, 7440–7445. 10.1021/acs.orglett.3c03059. [DOI] [PMC free article] [PubMed] [Google Scholar]; Note: In this paper, one similar system (compound 6f) was engaged for diastereoselective transformation but resulted in poor dr (3:2) with moderate yield
  16. a Seyden-Penne J.Chiral Auxiliaries and Ligands in Asymmetric Synthesis; Wiley: New York, 1995. [Google Scholar]; b Ojima I.Catalytic Asymmetric Synthesis, 3rd ed.; Wiley: New York, 2010. [Google Scholar]; c Ager D. J.; Prakash I.; Schaad D. R. Chiral Oxazolidinones in Asymmetric Synthesis. Aldrichimica Acta 1997, 30, 3–12. [Google Scholar]; d Zappia G.; Gacs-Baitz E.; Monache G. D.; Misiti D.; Nevola L.; Botta B. Oxazolidin-2-one Ring, a Popular Framework in Synthetic Organic Chemistry: Part 1. The Construction of the Oxazolidin-2-one Ring. Curr. Org. Synth. 2007, 4, 81–135. [Google Scholar]; e Zappia G.; Gacs-Baitz E.; Delle Monache G.; Misiti D.; Nevola L.; Botta B. Oxazolidin-2-one Ring, a Popular Framework in Synthetic Organic Chemistry Part 2 [1]. Applications and Modifications. Curr. Org. Synth. 2007, 4, 238–307. [Google Scholar]
  17. Fernandes G.; Scarim C. B.; Kim S. H.; Wu J.; Castagnolo D. Oxazolidinones as Versatile Scaffolds in Medicinal Chemistry. RSC Med. Chem. 2023, 14, 823–847. 10.1039/D2MD00415A. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jiang H.; Yu X.; Daniliuc C. G.; Studer A. Three-Component Aminoarylation of Electron-Rich Alkenes by Merging Photoredox with Nickel Catalysis. Angew. Chem., Int. Ed. 2021, 60, 14399–14404. 10.1002/anie.202101775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. a Soural M.; Bouillon I.; Krchňák V. Combinatorial Libraries of Bis-heterocyclic Compounds with Skeletal Diversity. J. Comb. Chem. 2008, 10, 923–933. 10.1021/cc8001074. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Lu H. Y.; Barve I. J.; Selvaraju M.; Sun C. M. One-Pot Synthesis of Unsymmetrical Bis-Heterocycles: Benzimidazole-Benzoxazole-and Benzothiazole-Linked Thiazolidines. ACS Comb. Sci. 2020, 22, 42–48. 10.1021/acscombsci.9b00161. [DOI] [PubMed] [Google Scholar]; c Bemis G. W.; Murcko M. A. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39, 2887–2893. 10.1021/jm9602928. [DOI] [PubMed] [Google Scholar]
  20. Tan G.; Paulus F.; Rentería-Gómez Á.; Lalisse R. F.; Daniliuc C. G.; Gutierrez O.; Glorius F. Highly Selective Radical Relay 1, 4-Oxyimination of Two Electronically Differentiated Olefins. J. Am. Chem. Soc. 2022, 144, 21664–21673. 10.1021/jacs.2c09244. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

cs4c04568_si_001.pdf (11.9MB, pdf)

Articles from ACS Catalysis are provided here courtesy of American Chemical Society

RESOURCES